Psychedelic stocks have recently been punished by the market. The flip-side is that many well-capitalized companies now offer spectacular value propositions.

The Drug Enforcement Administration (DEA) has yet again increased its quota for the legal production of illegal controlled substances like psilocybin, MDMA and DMT for research purposes in 2022.

atai Life Sciences adds to its holding in Compass Pathways, raising its ownership interest back to 20.8%.

Compass Pathways provides further details on its Phase IIb results for the treatment of Treatment Resistant Depression, including reporting of additional “patient improvements”.

Novamind expands its treatment footprint via a new partnership with Uruguay-based Bienstar Wellness.

Delic Holding Corp’s subsidiary, Ketamine Wellness Centers, is planning to open two new clinics, in Salt Lake City, Utah

A lawmaker in Kentucky on Monday took the first legislative steps toward legalizing cannabis in the Bluegrass State.

Novamind reports revenues of CAD$1.86 million for Q1 fiscal 2022, a 113% year-over-year increase. The company has total working capital of CAD$6.8 million

Red Light Holland reports its results for Q2 fiscal 2021. – Quarterly revenues up to CAD$485,738 – A 64% increase in gross profit
– 56% increase in the number of retail outlets selling TRIP products

A Florida lawmaker introduced a bill last week to decriminalize all currently illicit drugs, provide avenues for relief for those with existing drug-related convictions and promote harm reduction services.